Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: A post-hoc analysis of the PROLONG study

Haematologica

Volumn 93, Issue 6, 2008, Pages 900-907

  Legnani, Cristina ^a   Palareti, Gualtiero ^a   Cosmi, Benilde ^a   Cini, Michela ^a   Tosetto, Alberto ^b   Tripodi, Armando ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Anticoagulation; D dimer; Recurrence; Risk factors; Venous thromboembolism

Indexed keywords

ANTIVITAMIN K; D DIMER;

AGED; APPARATUS; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PREDICTION; QUALITATIVE ANALYSIS; QUANTITATIVE ASSAY; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; CLINICAL TRIALS AS TOPIC; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; RECURRENCE; RISK; VENOUS THROMBOEMBOLISM; VITAMIN K;

EID: 44949178264     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12320     Document Type: Article

References (31)

1. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007;92:199-205.
2. Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997;336:393-8.
3. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7.
4. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, et al. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003;139:19-25.
5. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med 2001;345:165-9.
6. Pinede L, Ninet J, Duhaut P, Chabaud S, DemolombeRague S, Durieu I, et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001;103:2453-60.
7. van Dongen CJJ, Hutten BA, Buller HR, Prins MH. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event - a meta-analysis. Arch Intern Med 2003;163:1285-93.
8. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996;348:423-8.
9. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002;87:7-12.
10. Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenbergen P, Schneider B, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA 2003;290:1071-4.
11. Palareti G, Legnani C, Cosmi B, Valdre L, Lunghi B, Bernardi F, et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003;108:313-8.
12. Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, et al. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost 2006;4:1208-14.
13. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006;355:1780-9.
14. Michiels JJ, Freyburger G, van der Graaf F, Janssen M, Oortwijn W, van Beek EJR. Strategies for the safe and effective exclusion and diagnosis of deep vein thrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonography. Semin Thromb Hemost 2000;26:657-67.
15. Heim SW, Schectman JM, Siadaty MS, Philbrick JT. D-dimer testing for deep venous thrombosis: a metaanalysis. Clin Chem 2004;50:1136-47.
16. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism - a systematic review. Ann Intern Med 2004;140:589-602.
17. Perrier A, Palareti G. D-dimer testing and venous thromboembolism: four view points. J Thromb Haemost 2005;3:382-4.
18. Gaffney PJ. Distinction between fibrinogen and fibrin degradation products in plasma. Clin Chim Acta 1975;65:109-15.
19. Adema E, Gebert U. Pooled patient samples as reference material for D-dimer. Thromb Res 1995;80:85-8.
20. Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Thromb Haemost 1997;77:1031-3.
21. Dempfle CE, Zips S, Ergul H, Heene DL. The Fibrin Assay Comparison Trial (FACT) - Evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. Thromb Haemost 2001;85:671-8.
22. Dempfle CE. D-dimer: standardization versus harmonization. Thromb Haemost 2006;95:399-400.
23. Meijer P, Haverkate F, Kluft C, deMoerloose P, Verbruggen B, Spannagl M. A model for the harmonisation of test results of different quantitative D-dimer methods. Thromb Haemost 2006;95:567-72.
24. Palareti G, Cosmi B, Legnani C. Diagnosis of deep vein thrombosis. Semin Thromb Hemost 2006;32:659-72.
25. Hager K, Platt D. Fibrin degeneration product concentrations (D-dimers) in the course of ageing. Gerontology 1995;41:159-65.
26. Pieper CF, Rao KMK, Currie MS, Harris TB, Cohen HJ. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci 2000; 55:M649-M57.
27. Bounameaux H, Demoerloose P, Perrier A, Miron MJ. D-dimer testing in suspected venous thromboembolism: an update. QJM 1997;90:437-42.
28. Tardy B, Tardyponcet B, Viallon A, Lafond P, Page V, Venet C, et al. Evaluation of D-dimer ELISA test in elderly patients with suspected pulmonary embolism. Thromb Haemost 1998;79:38-41.
29. Righini M, Goehring C, Bounameaux H, Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med 2000;109:357-61.
30. Le Blanche AF, Siguret V, Settegrana C, Bohus S, Le Masne de Chermont E, Andreux JP, et al. Ruling out acute deep vein thrombosis by ELISA plasma D-dimer assay versus ultrasound in inpatients more than 70 years old. Angiology 1999;50:873-82.
31. Baglin T. Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet. J Thromb Haemost 2006;4:2530-2.